Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study

被引：4

作者：

Iyngkaran, Pupalan ^{[1
,2
]}

Hanna, Fahad ^{[3
]}

Andrew, Sharon ^{[4
]}

Horowitz, John David ^{[5
]}

Battersby, Malcolm ^{[6
]}

De Courten, Maximilian Pangratius ^{[7
]}

机构：

[1] Torrens Univ, Heart Failure & Cardiac Imaging, Melbourne, VIC, Australia

[2] Univ Notre Dame, Werribee Mercy Sub Sch, Sch Med, Werribee, VIC, Australia

[3] Torrens Univ Australia, Publ Hlth, Melbourne, VIC, Australia

[4] Victoria Univ, Inst Hlth & Sport, Melbourne, VIC, Australia

[5] Univ Adelaide, Basil Hetzel Inst Translat Hlth Res, Adelaide, SA, Australia

[6] Flinders Univ S Australia, Flinders Hlth & Med Res Inst, Coll Med & Publ Hlth, Southern Adelaide Local Hlth Network Mental Hlth S, Bedford Pk, SA, Australia

[7] Victoria Univ, Mitchell Inst, Melbourne, VIC, Australia

来源：

FRONTIERS IN MEDICINE | 2023年 / 10卷

关键词：

congestive heart failure; Flinders program; mixed methods research methodology; protocol; risk assessment; self-management; QUALITY-OF-CARE; SCIENTIFIC STATEMENT; CARDIAC SOCIETY; AUSTRALIA; SUPPORT; FOUNDATION; PREVENTION; GUIDELINES; CARDIOLOGY; VALIDITY;

D O I：

10.3389/fmed.2023.1059735

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

IntroductionCongestive heart failure (CHF) causes significant morbidity and mortality. It is an epidemic, and costs are escalating. CHF is a chronic disease whose trajectory includes stable phases, periods of decompensation, and finally palliation. Health services and medical therapies must match the various patient needs. Chronic disease self-management (CDSM) programmes that are patient-focused, identify problems and set actionable goals that appear as a logical, cost-friendly method to navigate patient journeys. There have been challenges in standardising and implementing CHF programmes. Methods and analysisSELFMAN-HF is a prospective, observational study to evaluate the feasibility and validity of the SCRinHF tool, a one-page self-management and readmission risk prediction tool for CHF, with an established, comprehensive CDSM tool. Eligible patients will have CHF with left ventricular ejection fraction <40% and commenced sodium glucose co-transporter-2 inhibitors (SGLT2-i) within 6 months of recruitment. The primary endpoint is the 80% concordance in readmission risk predicted by the SCRinHF tool. The study will recruit >40 patients and is expected to last 18 months. Ethics and disseminationThis study has been approved by the St Vincent's ethics committee (approval no. LRR 177/21). All participants will complete a written informed consent prior to enrolment in the study. The study results will be disseminated widely via local and international health conferences and peer-reviewed publications.

引用

页数：11